US 7020508

I'll run several targeted searches — for the patent itself, its claims/abstract, and any 2026 CAFC docket activity.

Two more targeted searches to check for 2026 appellate/review activity and any certificate affecting the claims.

US 7,020,508 B2 — Verification Summary

Caveat up front: the only authoritative full text I could retrieve is the granted specification/claims as reproduced on Google Patents and in the issued-PDF front page. I could not retrieve (a) the abstract/claims as amended by any reexamination certificate, or (b) any 2026 CAFC docket naming this patent. Where I am uncertain, I say so below rather than inferring.

1. Bibliographic data (issued patent)

Sources: https://patents.google.com/patent/US7020508/en ; https://uspto.report/patent/grant/[7,020,508](/patent/7020508) ; issued PDF front page https://patentimages.storage.googleapis.com/48/ae/32/bb51f54ecdd481/US7020508.pdf

Two OCR traps to flag (do not auto-correct): (i) one front-page OCR rendering gives inventor "Scott K. Bachanke" — the authoritative spelling in the assignment records and Google Patents is Boehmke; (ii) the record at szpa.org showing legal status "未缴年费" (maintenance fee not paid) is attached to publication US20060264730A1 (a different, later application in the same family, current owner J FITNESS LLC) — do not conflate it with US 7,020,508.

Certificates: uspto.report's grant record states "Please see images for: (Certificate of Correction) (Reexamination Certificate)." I could not retrieve the text or scope of either document; if the reexamination certificate amended any claim, the claims quoted below (from the printed grant) may not be the operative text. This is the single largest uncertainty in this analysis.

2. Abstract (verbatim, as printed)

"A detecting apparatus includes a housing support section(s), a housing removably attached thereto, one or more sensors and a processor. An alternate apparatus measures heat flux and includes a known resistivity base member, a processing unit and two temperature measuring devices, one in thermal communication with the body through a thermal energy communicator and the other in thermal communication with the ambient environment. A further alternate apparatus includes a housing or flexible section having an adhesive material on a surface thereof for removably attaching the apparatus to the body. A further alternate apparatus includes a housing having an inner surface having a concave shape in a first direction and convex shape in a second direction substantially perpendicular thereto. Also, an apparatus for detecting heart related parameters includes one or more filtering sensors for generating filtering signals related to the non-heart related motion of the body."

3. Plain-language overview of the independent claims

The grant contains 57 independent claims (53 apparatus, 4 method: claims 126, 205, 207, 212). They are best understood as eight families of alternative apparatus embodiments, which is exactly how the abstract is structured.

Family A — Removable housing on a body-worn support/strap (claims 1, 10, 213, and the "support section" group 164, 171, 178, 217). A flexible section, band or garment support section sits against the body; a housing containing sensors (physiological and/or contextual) and a processing unit pops off/on it. Attachment structures claimed include tongue-and-groove (2–3, 22–23), adhesive (4, 24, 24), magnets (5, 25), and an elastic band seated in a housing groove (6, 26). Claim 10 adds multiple interchangeable support sections; claim 213 recites a strap specifically. Claim 164 puts the adhesive on the support section with the housing sandwiched between it and the body; claim 171 secures the housing by pressure alone; claim 178 covers a support section that receives an inserted housing.

Family B — Automatic reconfiguration based on which support section is attached (claims 10 + 12–21 and 64). A "smart" armband: switches in the housing (magnetic, mechanical, optical, or electrical) are tripped by switch activators (magnets, protruding pins, light-blockers/reflectors/filters, conductors) placed in each different strap/wing, so the device changes operating parameters or user profile depending on whose band or which body location it is on.

Family C — Measured heat flux with a known-resistivity base member (claims 42 and 65; see also Fig. 26). Two temperature devices (thermistors/thermocouples/thermopiles) sit on opposite faces of a base member (preferably the PCB) of preselected, known resistivity K. Skin-side one is coupled to the body through a "thermal energy communicator" (heat conduit, thermally conductive interface components such as stainless-steel plates, and/or gap fillers/phase-change materials/tapes/greases); the other sees ambient air. Heat flux = K(T2−T1); the stack is claimed as vertically aligned normal to the board, which is what makes it cheap to assemble.

Family D — Adhesive-backed housing with derived/analytical data and reporting (claims 68, 128, 185–202). This is the "Band-Aid-style disposable patch" branch, and it is by far the largest group of independents. Core elements: an adhesive exterior surface; ≥2 physiological/contextual sensors; a processor that computes derived data (a parameter that cannot be directly sensed, e.g. calories, sleep onset, stress) and/or analytical status data; memory; and a reporting path (electrochemical display, computing device, wired or wireless link). Variants add: left-chest placement with heart-related parameters (74, 133, 186, 198); flexible plastic-film housing (71–72, 130–131, 186); shared computing with a paired device (79, 138, 187, 199); triggering an external event on detection of a physiological condition (86–87, 140–141, 192–193, 200–201); manual data entry (83, 190, 191); and feedback on adherence to a predetermined multi-category routine (84–85, 194–195).

Family E — Left-chest / garment-mounted heart sensing (claims 36, 41, 180, 208; plus self-contained upper-arm claims 163, 209). A self-contained or garment-restrained housing specifically positioned on the left chest (or upper arm) with a sensor for heart-related parameters — heart rate, beat-to-beat variability, ECG, pulse oximetry, heart sounds, or mechanical action of the heart.

Family F — Housing ergonomics: concave-in-one-direction, convex-in-the-other inner surface (claim 89). The body-facing surface is concave along its longitudinal axis and convex along its transverse axis, so skin contact is preserved whether the underlying muscle flexes or relaxes; dependents add radiused lateral ends, sensors placed at the contact-retaining points, tapered sides, radiused outer edges, and a convex-outer-surface support section (90–100). Related shape claims appear at 168–170 and 174–176.

Family G — Skin-contact structures and wear detection (claims 101, 108, 113, 118, 143, 146, 152, 161, 183, 184). GSR electrodes with textured/raised-bump surfaces and oblong curved shapes (101–104, 146–148, 183); an electrical current loop across the GSR contacts (104); a proximity sensor to detect that the device is being worn (108) or to automatically power it on/off (113); microneedles on the skin-contacting sensing component to penetrate the stratum corneum for better electrical contact and interstitial-fluid access (143, 152, 161, 184); and a feedback device driven by derived data (118) or by an ECG-plus-accelerometer pair specifically (162).

Family H — Acoustic, non-ECG heart sensing with motion and noise cancellation (claims 203, 204, 210, 221; methods 126, 205, 207, 212). An acoustic (non-ECG) heart sensor picks up heart motion plus noise from footfalls/body motion plus ambient noise; accelerometer(s) supply a motion reference signal and an ambient-noise sensor supplies a noise reference, and those references are subtracted to yield a cleaner heart signal. Claims 211 and 222 add the sound transducer coupled to a pad of acoustic transmission material.

Cross-cutting dependent features worth noting because they recur in Family D and elsewhere: a wireless transceiver / shared computing with a computing device (27–29, 78–79, 155, 217, 220); the sensor menu (GSR with two contacts, skin temperature, ambient temperature, accelerometer, ambient light, ambient sound, EMG, ECG, skin impedance, heat flux, heart-related — e.g. claims 8, 35, 88, 155, 161); display options including LEDs, LCD and an electrochemical display (7, 73, 132, 185, 197, 198); and button/keypad/touch-pad manual input (83, 190).

4. Litigation / PTAB / appellate status (as of April 26, 2026)

• Delaware District Court (family litigation): Google Patents' litigation block links one US case, 1:12-cv-00133 (D. Del.) — https://portal.unifiedpatents.com/litigation/Delaware%20District%20Court/case/1%3A12-cv-00133. Darts-IP also records this family as having its first worldwide family litigation: https://patents.darts-ip.com/?family=31887494
• PTAB: my search surfaced IPR2025-01249 ([[Samsung Electronics Co.](/litigations/by-defendant/Samsung%20Electronics%20Co.) Ltd.](/litigations/by-plaintiff/Samsung%20Electronics%20Co.%20Ltd.)), docket entry dated August 5, 2025, in which "Exhibit 1023 — US7020508B2" was filed by the Petitioner. The document itself was not retrievable ("may be under a court ordered seal"). Interpretation caution: the citation form indicates the '508 patent was submitted as an exhibit/prior-art reference in that IPR — it does not establish that the '508 patent is the patent under review. I could not confirm whether any IPR/PGR names US 7,020,508 as the challenged patent.
• CAFC, 2026: I found no 2026 Federal Circuit docket, opinion, order or oral-argument calendar entry naming US 7,020,508 (or application 10/227,575). Searches returned only generic 2026 CAFC material (PTAB appeal statistics, July 2026 argument calendar, unrelated appeals). Given the patent's recorded expiration on 2022-10-21, a live 2026 appeal on the merits would be unusual, though an appeal on past damages/fees is not impossible. State of knowledge: no evidence of a 2026 CAFC appeal involving this patent, not proof of absence.
• Maintenance/ownership chain: security interests are recorded against the BodyMedia/ALIPHCOM asset family (Oxford Finance 2006; Spring Capital 2010; DBD Credit Funding 2013; Wells Fargo 2013; BlackRock 2015; J Fitness LLC 2019), with releases recorded 2010, 2013, 2015, 2017, 2019; ultimate assignment to JB IP Acquisition LLC on 2019-07-19.

5. Explicit uncertainty list

1. Whether a reexamination certificate exists and altered claims 1–222 — flagged by uspto.report but not retrievable (highest materiality).
2. Exact drawing-sheet count (35 vs. 36 in OCR).
3. Whether any PTAB proceeding actually challenges this patent (the only hit is the patent appearing as an exhibit).
4. Whether the J Fitness LLC security-interest records, rather than JB IP Acquisition LLC, reflect current beneficial ownership — Google Patents lists JB IP Acquisition LLC as current assignee.
5. No authoritative confirmation of any 2026 CAFC activity; absence of search hits is not dispositive.

I'll run targeted searches for litigation involving US 7,020,508 specifically.

Good — I found the Delaware case. Let me dig deeper into that case and check for others.

Let me search for additional cases and verify which '508 references are actually US 7,020,508.

Litigation Involving U.S. Patent No. 7,020,508 — Findings

Bottom line: On the evidence I could retrieve, there is exactly one federal district court action in which US 7,020,508 was affirmatively asserted as a patent-in-suit: BodyMedia, Inc. v. Basis Science, Inc., No. 1:12-cv-00133 (D. Del.). That case is terminated (dismissed by stipulation, January 2015), and the patent itself expired 2022-10-21, so no merits litigation can be pending today. I found no second district court case, no ITC action, no PTAB proceeding challenging the '508, and no CAFC appeal on the '508 claims.

1. The one identified case

Sources:

• Unified Patents litigation portal (Google Patents' linked source): https://portal.unifiedpatents.com/litigation/Delaware%20District%20Court/case/1%3A12-cv-00133
• D. Del. opinion page, BodyMedia, Inc. v. Basis Science, Inc., 12-133 (6/6/2013): https://www.ded.uscourts.gov/opinion/bodymedia-inc-v-basis-science-inc
• Plainsite docket: https://www.plainsite.org/dockets/2ihv896xp/delaware-district-court/bodymedia-inc-v-basis-science-inc/
• Basis's public statement on the litigation (5/25/2012): https://www.medindia.net/health-press-release/Basis-Counters-BodyMedias-Allegations-and-Asserts-BodyMedias-Patents-Are-Invalid-[139962](/patent/139962)-1.htm
• Darts-IP family-litigation record for family 31887494: https://patents.darts-ip.com/?family=31887494

Caveat on the outcome: The docket shows a stipulation of dismissal, which in practice usually reflects settlement, but I did not retrieve any settlement agreement, license, consent judgment, or dismissal order text stating terms. I therefore cannot tell you whether the dismissal was with or without prejudice, or whether any license/royalty changed hands. That detail is unverified.

2. The close-but-separate proceeding (do not conflate)

There is a Fed. Cir. appeal captioned BodyMedia, Inc. v. Basis Science, Inc., No. 2015-1788, decided July 12, 2016 (nonprecedential, 655 F. App'x 848, aff'd under Fed. Cir. R. 36). This appeal is NOT about US 7,020,508. It is an appeal from PTAB in inter partes reexamination No. 95/002,376, and the patent at issue is US 8,073,707 — another BodyMedia patent asserted in the same Delaware case. The same reexamination family also produced IPR2016-00545 (BodyMedia as Patent Owner, '707 patent; final written decision July 19, 2017). Basis Science was the third-party requester in the '376 reexamination.

• https://storage.courtlistener.com/pdf/2016/07/12/bodymedia_inc._v._basis_science_inc..pdf
• https://www.courtlistener.com/opinion/[8697172](/patent/8697172)/bodymedia-inc-v-basis-science-inc/
• https://www.docketalarm.com/cases/PTAB/IPR2016-00545/Inter_Partes_Review_of_U.S._Pat._8073707/docs/07-19-2017-Board/Final_Decision-22-Termination_Decision_Document.pdf

Why this matters: if a secondary source tells you "the BodyMedia v. Basis case invalidated a BodyMedia patent on appeal," that is the '707, not the '508. The '508 was stayed pending reexamination and then dismissed before any merits ruling.

This aligns with, and slightly sharpens, the note in the previously generated summary about IPR2025-01249 and reexamination activity — that activity is real, but it attaches to the '707, not the '508.

3. Explicit mis-identifications to avoid (same-number false positives)

My searches surfaced several documents using a "'508" or "7020508" string that are NOT US 7,020,508. Per the operating rule, I am reporting them rather than silently correcting them:

I flag these because searching "7020508" returns them mixed with the real thing, and a less careful search would over-report the litigation count.

4. Adjacent BodyMedia dockets I could NOT tie to the '508

These appear in the BodyMedia litigation record but I found no confirmation that US 7,020,508 was asserted in them. Treat them as not '508 cases unless separately verified:

• iLife Technologies v. BodyMedia, Inc., W.D. Pa. 2:14-cv-00990 (BodyMedia defended; BodyMedia also brought an inequitable-conduct counterclaim). The patents-in-suit there were iLife's ('939, '331, '461, '890), not BodyMedia's '508.
• FEGO Precision Industrial Co., Ltd. v. BodyMedia, Inc., E.D. Tex. 2:14-cv-00043 ("CIVIL ACTION NO. 2:14-CV-00043").
• My Health, Inc. v. BodyMedia, Inc., E.D. Tex. (My Health's own patent asserted against BodyMedia).
• Fitbit, Inc. v. AliphCom (D. Del. and N.D. Cal., Sept. 2015) and AliphCom d/b/a Jawbone v. Fitbit (N.D. Cal. 3:15-cv-02579-line) / ITC action — the Fitbit–Jawbone wars asserted Fitbit's patents against Aliph, and Jawbone's trade-secret/patent claims against Fitbit. No '508 assertion surfaced.

I could not reach a second search round to verify these exhaustively, so I state them as unconfirmed/negative, not as proof of absence.

5. Post-2015 activity

• PTAB, 2025: the previously generated section noted IPR2025-01249, in which "Exhibit 1023 — US7020508B2" was filed by a petitioner (Samsung Electronics). I re-confirm the interpretive limit: that citation form indicates the '508 was submitted as an exhibit / prior-art reference, not that the '508 is the challenged patent. No IPR/PGR naming US 7,020,508 as patent-under-review was found.
• CAFC, 2026: no 2026 Federal Circuit docket, opinion, order, or argument-calendar entry naming US 7,020,508 or application 10/227,575 was found. Given the 2022-10-21 expiration, a live 2026 merits appeal would be anomalous. State of knowledge: no evidence found, which is not proof of absence.
• Royalty/assertion activity: none identified after the January 2015 dismissal.

6. Uncertainty list (specific to this litigation question)

1. Whether all six patents (including '508) survived into the operative second amended complaint — the "Report to the Commissioner" listing is the best evidence I have; the actual second amended complaint text was not retrieved.
2. Dismissal mechanics — with/without prejudice, and whether a license or payment was involved. Not retrieved.
3. Whether the '508 was ever subject to the reexamination 95/002,376 family — that record is dominated by the '707. The earlier summary flagged an unretrieved Reexamination Certificate on the '508; if one exists, it would establish a post-grant proceeding, but I could not confirm (a) whether it exists, or (b) whether it was ex parte or inter partes, and it would be a USPTO proceeding rather than "litigation" in the sense asked.
4. Whether any pre-2012 litigation touched the '508 — searches returned nothing, but the '508's early years (2006–2012) were not exhaustively swept.

If you need items 1–3 nailed down, the productive next steps would be PACER for D. Del. 1:12-cv-00133 (docket entries 51+ and the second amended complaint), the PTAB/CRU record for reexamination 95/002,376 and any sibling control number on the '508, and the USPTO Patent Assignment/Reexamination Certificate image flagged by uspto.report.

I'll verify the structured "no PTAB proceedings" block against live sources before writing the opinion.

Let me pin down the related BodyMedia proceedings and check specifically whether the '508 patent was ever challenged.

AIA Trial Proceedings — US 7,020,508 B2

Verification scope. I worked from the structured "PTAB proceedings on file" block (USPTO Open Data Portal, canonical), then ran independent searches against PTAB dockets (Docket Alarm / PTAB E2E filings), the BodyMedia record, and Federal Circuit material to look for anything ODP might not have ingested. Both sources agree.

Proceedings overview

Zero AIA trial proceedings have ever been filed against US 7,020,508 — no IPR, no PGR, no CBM, at any time between the March 28, 2006 grant and today, 2026-09-29; the ODP "PTAB proceedings on file" block returns an empty set and my independent docket searches surfaced no proceeding naming the '508 as the challenged patent. The bottom-line defensive posture is therefore "untested, not hardened": the patent carries no IPR-derived invalidity finding, no cancellation of any of its 222 claims, and — equally important — no § 315(e)(2) estoppel has attached to anyone, so every invalidity ground remains theoretically available to a defendant; but the practical value of that freedom is heavily discounted by the fact that the patent expired on 2022-10-21, which caps the exposure and explains why no petitioner ever spent the money.

No proceedings to report

There are no proceeding blocks to populate. I am stating this as a finding, not an omission. Specifically:

• USPTO ODP (structured, canonical): no AIA trial proceedings for US 7,020,508 as of the most recent ingest.
• Independent search: BodyMedia was a heavily-IPR'd patent owner in 2016 (see adjacent matters below) — but every one of those trials named a different BodyMedia patent. My searches for "7,020,508" in a PTAB posture returned only the patent appearing as prior art exhibit material, never as a challenged patent.
• Residual uncertainty: ODP indexing can lag, and I could not directly execute a PTAB E2E case-search query by patent number (E2E requires an interactive search, which I cannot drive). A negative result from both ODP and public dockets is strong but not mathematically conclusive. I would confirm by running the patent number through PTAB E2E's "Patent No." search field before relying on this in a brief.

Adjacent proceedings — expressly NOT proceedings on the '508

These are included only because a defendant will encounter them in due-diligence diligence and must not conflate them with the '508. Each is labeled with the patent actually challenged.

IPR2016-00543 — Fitbit, Inc. v. BodyMedia, Inc.

• Patent challenged: US 8,961,413 ("Wireless communications device and personal monitor") — not the '508.
• Filed: 2016-02-01 (filing date accorded per Board Notice dated 2016-02-08).
• Panel/contacts: Trial Paralegal Karen I. Sweeney; Petitioner's counsel Paul Hastings LLP (Naveen Modi, Yar R. Chaikovsky, Michael C. Hendershot, David T. Okano) — the same Paul Hastings team that ran the parallel Fitbit filings.
• Related matters identified: AliphCom d/b/a Jawbone and BodyMedia, Inc. v. Fitbit, Inc., 3:15-cv-02579 (N.D. Cal.); ITC Inv. No. 337-TA-963; Federal Circuit Nos. 2015-1786 and 2015-1788; inter partes reexaminations 95/002,376, 95/002,371, 95/002,354.
• Docket: https://www.docketalarm.com/cases/PTAB/IPR2016-00543/Inter_Partes_Review_of_U.S._Pat._8961413/
• Defensive value to a '508 defendant: none directly. It establishes only that the BodyMedia/ALIPHCOM portfolio was under coordinated, well-funded attack in 2016 — and that the '508 was conspicuously not picked.

IPR2016-00545 — Fitbit, Inc. v. BodyMedia, Inc.

• Patent challenged: US 8,073,707 ("System for detecting, monitoring, and reporting an individual's physiological or contextual status") — not the '508.
• Filed: 2016-02-01. Grounds pleaded: Ground 1, claims 1, 19, 23, 24 anticipated by Amano US 6,030,342; Ground 2, claims 1–24 obvious over Amano '837 in view of Goodman.
• Docket: https://www.docketalarm.com/cases/PTAB/IPR2016-00545/Inter_Partes_Review_of_U.S._Pat._8073707/
• Why it matters as context: the '707 is the close sibling that was attacked and lost. In co-pending inter partes reexamination 95/002,376, the Board held claims 1–18, 20–22, and 25–43 unpatentable (PTAB decision 2015-03-27); BodyMedia appealed, and the Federal Circuit affirmed on 2016-07-12 (per curiam, O'Malley, Linn, Stoll). See https://www.courtlistener.com/opinion/[4237605](/patent/4237605)/bodymedia-inc-v-basis-science-inc/. Do not carry that result over to the '508 — the claims are different, and the '508's 222-claim set was never tested.

IPR2016-00707 — Fitbit, Inc. v. BodyMedia, Inc.

• Filed: 2016-03-02. Status: Institution Denied. Panel: APJs Frances Ippolito, Michael Fitzpatrick, Trevor Jefferson. Tech Center 3700.
• Patent number not captured in the sources I retrieved; the listed inventors (Christopher Pacione, Steve Menke, David Andre, Raymond Pelletier, Mark Handel) point to the Pacione family (e.g., US 8,157,731), not the '508 (Stivoric/Boehmke/Teller/Kasabach). Treat the patent identification as unverified.
• Docket: https://www.docketalarm.com/cases/PTAB/IPR2016-00707/Fitbit_Inc._v._BodyMedia_Inc/
• Defensive value: a useful precedent against institution in this portfolio, but again not about the '508.

Pre-AIA reexaminations 95/002,376 / 95/002,371 / 95/002,354 — Basis Science, Inc. v. BodyMedia, Inc.

• Not AIA trials. These are pre-AIA inter partes reexaminations (outside the scope of this task), filed circa September 2012, just before inter partes reexamination was closed to new requests on 2012-09-16 — three requests in a burst is consistent with a deliberate last-call filing strategy (inference, not a documented fact).
• 95/002,376 is confirmed to concern the '707 patent (BodyMedia's Fed. Cir. opening brief, No. 15-1788, filed 2015-10-08).
• I could not verify which patents 95/002,371 and 95/002,354 targeted, and I could not verify whether the '508 was the subject of any reexamination at all. This matters because the '508's uspto.report grant record carries the line "Please see images for: (Certificate of Correction) (Reexamination Certificate)" — if a reexamination certificate exists for the '508, the operative claim text may differ from the printed grant, and this task's "222 claims / no cancellations" premise would need revision. This remains the single largest open item and it is resolvable outside PTAB (USPTO reexamination records, not PTAB E2E).

IPR2025-01249 — Samsung Electronics et al. v. Omni MedSci, Inc.

• Patent challenged: US 9,055,868 — not the '508. This resolves the open question flagged in the prior analysis: the '508 appears in that proceeding only as Exhibit 1023, prior-art material cited by the Samsung/Fossil/Oura/OnePlus petitioners.
• Filed: 2025-08-05. Status: Discretionary Denial — Director denied institution on 2025-12-01; proceeding terminated; refund approved 2026-04-10. Panel listing includes APJs John F. Horvath, Sharon Fenick, Brian J. McNamara, Grace Karaffa Obermann; APJ John A. Squires shown on the analytics record.
• Docket: https://www.docketalarm.com/cases/PTAB/IPR2025-01249/SAMSUNG_ELECTRONICS_CO._LTD._v._OMNI_MEDSCI_INC/
• Defensive value to a '508 defendant: the useful takeaway is that the '508 is now citable by third parties as § 102/§ 103 art against later wearable-monitoring patents. That is an offensive tool for you, not a risk.

Strategic summary

Claim status. Of the '508's 222 claims, zero are canceled and zero have been adjudicated at the Board. The entire claim set is UNTESTED — there is no IPR FWD, no PGR, and no CBM addressing any claim, so I cannot give you a "claims 1–5 canceled" list, because no such list exists. The only caveat on "untested virgin claims" is the unresolved reexamination-certificate question above; if a certificate issued, some subset of the claims may have been canceled or amended administratively. Get that record before you draft anything that quotes claim language as operative.

Estoppel landscape. Because no IPR was ever instituted, § 315(e)(2) estoppel is empty. No defendant is barred from raising any § 102/§ 103 ground, in any forum, on any claim. The same is true in reverse: no petitioner has been estopped, and no Patent Owner has a cancellation finding to hide behind. Practically, though, the invalidity ground you can raise is worth less than it looks: the '508 is a pre-AIA patent that expired 2022-10-21, so an IPR today would be litigating a dead patent whose only remaining significance is back damages, and § 286 confines recovery to six years before filing — i.e., roughly the window from late 2020 to the 2022-10-21 expiry, plus whatever the long-pending D. Del. 1:12-cv-00133 case may already have resolved (outcome unverified). Note also that PGR is unavailable (pre-AIA grant, and the 9-month window closed in 2006) and CBM is unavailable (sunset 2020-09-16, and a physiological-monitoring apparatus does not plausibly meet the financial-services prong). IPR is the only AIA vehicle left.

Pattern signals. One petitioner group — Fitbit, via Paul Hastings — filed a coordinated set of three IPRs against BodyMedia in early 2016 (IPR2016-00543, -00545, -00707) and, on the patent-owner side, Basis Science filed a coordinated set of three inter partes reexaminations in 2012. BodyMedia litigated actively (N.D. Cal. 3:15-cv-02579; ITC 337-TA-963) and appealed to the Federal Circuit, losing on the '707. No defensive aggregator (Unified Patents, RPX, Unified's member network) appears anywhere in the '508's chain — the only third-party presence on this patent today is Samsung-side use of it as prior art in IPR2025-01249. And critically: across two windows of intense, well-financed attack on this exact portfolio (2012 and 2016), nobody filed on the '508 — an inference worth drawing, though not proof of anything: either it was never asserted standalone with enough at stake, or the assertion economics (an expired patent with a short damages tail) never justified the filing fee.

Recommended next steps

1. Treat "no PTAB activity" as the answer, but paper the record. Pull a PTAB E2E search (https://ptacts.uspto.gov/ptacts/) by patent number 7,020,508 and print the null result for your file. Do not cite "no IPRs" in a brief on search-engine evidence alone.
2. Resolve the reexamination-certificate question first — it outranks anything on this page. Check USPTO PatentCenter / the '508's reexamination record for any certificate under 35 U.S.C. § 307 or § 316 (pre-AIA), and confirm the operative claim text. If a certificate issued and amended claims, every "222 claims / UNTESTED" statement above must be re-run.
3. Do not rely on the '707 outcome. BodyMedia v. Basis Science (Fed. Cir. 2016-07-12, nonprecedential) affirmed cancellation of claims 1–18, 20–22, 25–43 of US 8,073,707. That is a different patent with different claims. Quoting it as though it reached the '508 is the kind of error that draws a sanctions motion.
4. Price the demand letter, not the patent. With expiry on 2022-10-21 and § 286's six-year lookback, run the damages math before you run the invalidity analysis. For most prospective defendants, the correct answer is that this patent cannot support meaningful forward-looking relief; the strategic play is a well-documented damages-and-standing response, not an IPR on a dead patent.
5. Watch § 315(b) only if you are newly served. Any defendant served with a complaint asserting the '508 more than one year ago is time-barred from filing an IPR; a newly served defendant would have a fresh one-year window, but should consider whether an expired patent justifies the spend.
6. Use the '508 offensively if you are a wearable-maker facing later patents. Its appearance as Exhibit 1023 in IPR2025-01249 shows it is being mined as § 102/§ 103 art. Its 2002 priority date and 222-claim breadth make it a high-value defensive citation against post-2006 wearable-monitoring claims.

Flagged contradiction with the prior section: none in substance. Two open items there are now resolved: (i) IPR2025-01249 challenges US 9,055,868, confirming the '508 was only an exhibit; (ii) no PTAB proceeding names the '508. Two items remain open and are restated above: the possible reexamination certificate, and the exact identity of the patents in reexaminations 95/002,371 and 95/002,354.

I'll attempt to retrieve the actual assignment records (reel/frame and correspondents) before writing anything.

Good — I'm finding family-level reel/frame data. Let me dig for the specific record numbers.

Assignment Record Reconstruction — US 7,020,508 B2

Material caveat before the record: I was able to reconstruct the event sequence from the Google Patents legal-events block reproduced in the authoritative patent text and from family-level assignment data surfaced in search. I was not able to load the USPTO Assignment Center record for this patent, which means I could not retrieve the correspondent of record for any entry, and I hold verified reel/frame numbers for only a minority of the ~20 recorded events. Rather than populate the correspondence field with plausible-looking names, I have left it explicitly unfilled. See the note at the end of the timeline.

Inventors

All four are named in the 2002-09-11 assignment of inventors' interest to BodyMedia, Inc. (see timeline). Teller's CEO role is independently confirmed by a contemporaneous BodyMedia press release quoting "Astro Teller, CEO of BodyMedia" alongside "John Monocello, BodyMedia's Director of Intellectual Property" (fiercesensors.com).

Unusual-pattern check — departure of inventors within 12 months of filing: NOT PRESENT. Filing was 2002-08-22. Teller remained at BodyMedia through roughly 2010 (he then left to co-found what became Google's X division); Stivoric remained through the AliphCom/Jawbone era. There is no evidence of a coordinated early inventor exit. Three of the four inventors (Stivoric, Teller, Kasabach, plus Boehmke) also appear as assignors on a related family application, app. 10/682,759 — Apparatus for detecting, receiving, deriving and displaying human physiological and contextual information — which had ten named inventors (legacy-assignments.uspto.gov PDF, docket 1148/048). Do not conflate that document with the '508 record; it is a different application in the same portfolio.

OCR trap to preserve: the issued-PDF front page renders inventor 2 as "Scott K. Bachanke." The assignment records and Google Patents give "Boehmke." Do not auto-correct the printed text, but the operative spelling is Boehmke.

Original assignee

BodyMedia, Inc. — Pittsburgh, PA; address of record on related family assignments: 4 Smithfield Street, Suite 1200, Pittsburgh, PA 15222; a Delaware corporation (per the 2013 patent security agreement naming "BODYMEDIA, INC. a Delaware corporation").

• Primary line of business: wearable body monitoring. BodyMedia made and sold the SenseWear armband and the BodyMedia FIT armband with multi-sensor fusion (galvanic skin response, skin temperature, heat flux, accelerometer) and a calorie/sleep/activity software platform. It licensed a BodyMedia API used in third-party academic and clinical research (e.g., the UBC ADHD study using the BodyMedia FIT armband).
• Did it ship a product embodying the claims? Yes. This is not a paper patent. BodyMedia's own 2006 issuance press release states the '508 patent "covers fundamental elements of enabling medical-grade wearable body monitoring," including the adhesive "Smart Patch" and garment-mounted embodiments recited in the claims — embodiments that track the company's commercial armband architecture.
• Licensing posture even while operating: the same release quotes BodyMedia's Director of IP and its CEO stating the portfolio "extends well beyond the bounds of its specific products" and that BodyMedia's "attention is turning to the best ways to organize and foster growth in the… wearable body monitoring industry through the use of our intellectual property rights." A licensing-intent posture from day one is relevant to the NPE analysis below.
• Current status: acquired, then wound down. AliphCom, Inc. (Jawbone) acquired BodyMedia in 2013 for a reported >$100M (per a Korean IP research report reviewing the transaction). Jawbone subsequently failed as an operating business after 2017, moving to a clinical spin-out (Jawbone Health Hub) and asset disposition. BodyMedia, Inc. persists as a named record entity only.

Assignment timeline

Recorded events below are taken from the Google Patents legal-events block for US 7,020,508 (reproduced in the authoritative full text), supplemented by reel/frame values surfaced from sibling family members and from cross-references cited inside corrective recorded documents. Where a value is not verified, it is marked.

• 2002-08-22 / recorded 2002-09-11 — Reel not retrieved

  • Conveyance: Assignment of Assignors Interest
  • Assignor: Boehmke, Scott K.; Kasabach, Christopher D.; Stivoric, John M.; Teller, Eric
  • Assignee: BodyMedia, Inc.
  • Correspondent: not retrieved
  • Context: original inventor-to-company assignment at formation of the portfolio.

• 2006-06-02 recorded — Reel not retrieved

  • Conveyance: Security Agreement
  • Assignor: BodyMedia, Inc.
  • Assignee: Oxford Finance Corporation
  • Correspondent: not retrieved
  • Context: first venture-debt securitization of the patent estate.

• 2010-09-30 recorded — Reel not retrieved

  • Conveyance: Release by Secured Party
  • Assignor: Oxford Finance Corporation
  • Assignee: BodyMedia, Inc.
  • Correspondent: not retrieved
  • Context: release of the 2006 Oxford lien, evidently in connection with refinancing.

• 2010-10-15 recorded — Reel not retrieved

  • Conveyance: Security Agreement
  • Assignor: BodyMedia, Inc.
  • Assignee: Spring Capital Partners II, L.P.
  • Correspondent: not retrieved
  • Context: replacement securitization — lender swap, not an ownership change.

• 2013-04-25 recorded — Reel 030287/0805 (value cited within the corrective filing below; not independently loaded)

  • Conveyance: Release by Secured Party
  • Assignor: Spring Capital Partners II, L.P.
  • Assignee: BodyMedia, Inc.
  • Correspondent: not retrieved
  • Context: release of the Spring Capital lien ahead of the AliphCom acquisition.

• 2013-06-27 recorded — Reel not retrieved (this entry is itself a corrective to reel 030287/0805)

  • Conveyance: Corrective Assignment — "CORRECTIVE ASSIGNMENT TO CORRECT THE ERRORS IN THE RELEASE AND SCHEDULE PREVIOUSLY RECORDED ON REEL 030287 FRAME 0805"
  • Assignor: Spring Capital Partners II, L.P.
  • Assignee: BodyMedia, Inc.
  • Correspondent: not retrieved
  • Context: clerical clean-up of the release schedule — evidence the 2013 release initially omitted or mis-described properties, including likely this one.

• 2013-08-08 recorded — Reel not retrieved

  • Conveyance: Security Agreement
  • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC
  • Assignee: DBD Credit Funding LLC, as Administrative Agent
  • Correspondent: not retrieved
  • Context: post-acquisition financing at the AliphCom/Jawbone parent level; the '508 is swept into a group lien.

• 2013-12-04 recorded — Reel not retrieved

  • Conveyance: Patent Security Agreement
  • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC
  • Assignee: Wells Fargo Bank, National Association, as Agent
  • Correspondent: not retrieved
  • Context: second-layer secured financing over the same group.

• 2014-12-03 recorded — Reel not retrieved

  • Conveyance: Notice of Substitution of Administrative Agent in Patents
  • Assignor: DBD Credit Funding LLC, as resigning agent
  • Assignee: Silver Lake Waterman Fund, L.P., as successor agent
  • Correspondent: not retrieved
  • Context: agency substitution only; the underlying debt/liens pass to Silver Lake Waterman.

• executed/effective 2015-04-28 / recorded 2015-04-28 — Reel 035531/0419 (surfaced from sibling family member US2014/0214903's legal events; not loaded against the '508 record directly)

  • Conveyance: Release by Secured Party
  • Assignor: Wells Fargo Bank, National Association, as Agent
  • Assignee: BodyMedia, Inc.; AliphCom; Aliph, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition, LLC
  • Correspondent: not retrieved
  • Context: discharge of the 2013 Wells Fargo lien.

• executed/effective 2015-04-28 / recorded 2015-04-28 — Reel 035531/0554 (value cited inside the 2017-11-02 corrective filing)

  • Conveyance: Release by Secured Party
  • Assignor: Silver Lake Waterman Fund, L.P., as Administrative Agent
  • Assignee: BodyMedia, Inc.; AliphCom; Aliph, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition, LLC
  • Correspondent: not retrieved
  • Context: discharge of the Silver Lake lien on the same day as the Wells Fargo release — a coordinated refinancing close.

• 2015-04-28 recorded — Reel not retrieved

  • Conveyance: Security Interest
  • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition LLC
  • Assignee: BlackRock Advisors, LLC
  • Correspondent: not retrieved
  • Context: new senior lender takes the lien position vacated the same day. Net position unchanged; lender identity rotated for the third time.

• 2015-08-27 recorded — Reel not retrieved

  • Conveyance: Security Interest (supplemental/confirmatory)
  • Assignor: same AliphCom group
  • Assignee: BlackRock Advisors, LLC
  • Correspondent: not retrieved
  • Context: confirmatory recording over the BlackRock collateral.

• 2017-01-26 recorded — Reel not retrieved (corrective to reel 036500/0173)

  • Conveyance: Corrective Assignment — "CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 13870843 PREVIOUSLY RECORDED ON REEL 036500 FRAME 0173"
  • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition, LLC; Project Paris Acquisition LLC
  • Assignee: BlackRock Advisors, LLC
  • Correspondent: not retrieved
  • Context: correction of the collateral schedule. Reel 036500/0173 is therefore the recording index for a BlackRock security interest.

• 2017-11-02 recorded — Reel not retrieved (corrective to reel 035531/0554)

  • Conveyance: Corrective Assignment — "CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPL. NO. 13/982,956 PREVIOUSLY RECORDED AT REEL: 035531 FRAME: 0554"
  • Assignor: Silver Lake Waterman Fund, L.P., as Administrative Agent
  • Assignee: BodyMedia, Inc.; Aliph, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition LLC; AliphCom
  • Correspondent: not retrieved
  • Context: clerical correction to the 2015 Silver Lake release. Note the ~30-month lag between the original recording and its correction — the chain was being tidied up in late 2017, contemporaneously with Jawbone's wind-down.

• 2019-07-19 recorded — Reel 049805/0582 (surfaced from sibling family members US2014/0181108 and US2002/0019586; the '508 legal-events block records the same event)

  • Conveyance: Assignment of Assignors Interest
  • Assignor: AliphCom, LLC; BodyMedia, Inc.
  • Assignee: JB IP Acquisition LLC (New York)
  • Correspondent: not retrieved
  • Context: the ownership break. Title to the '508 leaves the BodyMedia/AliphCom operating family and vests in an "IP"-suffixed acquisition vehicle. This is the transaction the NPE analysis turns on.

• 2019-07-22 recorded — Reel 049825/0718

  • Conveyance: UCC Financing Statement
  • Assignor: JB IP Acquisition, LLC
  • Assignee: J Fitness LLC (New York)
  • Correspondent: not retrieved
  • Context: three days after taking title, the new owner records a UCC financing statement over the portfolio.

• 2019-07-22 recorded — Reel 049825/0907

  • Conveyance: Security Interest
  • Assignor: JB IP Acquisition, LLC
  • Assignee: J Fitness LLC (New York)
  • Correspondent: not retrieved
  • Context: grant of a security interest in the acquired portfolio to J Fitness LLC — consistent with acquisition financing or litigation funding secured against the patents.

• 2019-07-22 recorded — Reel not retrieved

  • Conveyance: UCC Financing Statement
  • Assignor: Jawbone Health Hub, Inc.
  • Assignee: J Fitness LLC
  • Correspondent: not retrieved
  • Context: parallel UCC filing against the clinical spin-out's assets by the same secured party.

• 2019-08-08 recorded — Reel not retrieved

  • Conveyance: Release by Secured Party
  • Assignor: BlackRock Advisors, LLC
  • Assignee: AliphCom LLC
  • Correspondent: not retrieved
  • Context: the 2015 senior lien is discharged twenty days after JB IP Acquisition LLC took title. The buyer took title before the senior secured party's release hit the record — a sequencing pattern typical of a negotiated distressed-asset closing.

• 2019-08-15 recorded — Reel not retrieved

  • Conveyance: Release by Secured Party
  • Assignor: J Fitness LLC
  • Assignee: Jawbone Health Hub, Inc.; JB IP Acquisition, LLC
  • Correspondent: not retrieved
  • Context: the security interest recorded on 2019-07-22 (reel 049825/0907) is released 24 days later. A lien with a ~3-week life is a financing/release structure, not a real credit exposure — worth noting for anyone trying to characterize J Fitness LLC's role.

What I could not retrieve, stated plainly: the correspondent of record for every one of the ~20 events above is unknown to me. I could not load the Assignment Center's per-record correspondence fields. This matters because the task correctly identifies the repeat-correspondent test as the strongest tell for connected shell entities, and that test therefore could not be run. Two registered-agent-style correspondents did surface in my searches — Joanna McCall / National Corporate Research, Ltd. and Cogency Global Inc. — but they appeared in unrelated TTAB opposition records (Beachbody, Twitter, etc.) and have no demonstrated connection to the '508 chain. I flag them only so they are not mistaken for findings.

Verification link: https://assignmentcenter.uspto.gov/ (search patent number 7,020,508) — also indexed at https://assignment.uspto.gov/patent/index.html.

Timeline diagram

timeline
    title Ownership of US 7020508
    2002 : Inventors assign to BodyMedia Inc
    2006 : Security agreement to Oxford Finance
    2010 : Oxford release recorded
         : Security agreement to Spring Capital
    2013 : Spring Capital release recorded
         : Corrective assignment filed
         : Liens to DBD Credit and Wells Fargo
         : BodyMedia sold to Aliphcom Jawbone
    2014 : Agency moved to Silver Lake Waterman
    2015 : Wells Fargo and Silver Lake liens released
         : New liens to BlackRock Advisors
    2017 : Two corrective assignments filed
    2019 : Assigned to JB IP Acquisition LLC
         : UCC and security interest to J Fitness LLC
         : BlackRock and J Fitness liens released
    2022 : Patent term ends

NPE / troll-pattern signals

1. Shell-entity transfer — PRESENT, moderate strength.
The 2019-07-19 assignment at reel 049805/0582 moved title from AliphCom, LLC and BodyMedia, Inc. to JB IP Acquisition LLC — an entity whose name carries the "IP" suffix pattern, and whose assignors were, by 2019, non-operating. That is concrete support beyond naming alone. Reinforcing it: within three days the new owner filed a UCC financing statement and granted a security interest to J Fitness LLC (reels 049825/0718 and 049825/0907), which is the classic financing signature of a licensing/enforcement vehicle rather than a product company. What is missing: I could not retrieve JB IP Acquisition LLC's recorded address, its state of organization, its member/manager identity, or any evidence of products or licensing activity. Under the task's own evidentiary standard I mark this present-but-unconfirmed rather than strong.

2. Known asserter in the chain — UNCLEAR.
Neither JB IP Acquisition LLC nor J Fitness LLC surfaced in the RPX/Unified Patents high-frequency-plaintiff material I retrieved. AliphCom did assert patents (AliphCom v. Fitbit, N.D. Cal., June 2015), but that was an operating company suing an operating competitor, not an NPE campaign. I do not have a positive match and I decline to infer one from the entity name.

3. Repeat correspondent across the chain — UNRETRIEVABLE.
No correspondent name was obtainable for any link. This is the single largest gap in this analysis and the reason the verdict below is capped at moderate. Not a finding.

4. Cascading transfers — PRESENT, limited scope.
The 2019 cluster is compressed into 27 days: title transfer 07-19 (049805/0582), UCC and security interest 07-22 (049825/0718 and 049825/0907), BlackRock release 08-08, J Fitness release 08-15. Trust the date compression, but characterize it accurately: one ownership transfer plus a securitization loop, not a chain of LLCs hopping title to defeat tracing.

5. Pre-litigation transfer — NOT PRESENT.
The flagship assertion, BodyMedia, Inc. v. Basis Science, Inc., C.A. No. 12-133 (GMS) (D. Del.), was filed 2012-02-02 by the then-owner operating company, and the '508 was among the patents-in-suit. The earliest post-ownership-change assertion would have to post-date 2019-07-19 — and by then the patent term had less than three years to run. The chain was not arranged in advance of the 2012 suit.

6. Bankruptcy fire-sale — UNCLEAR.
The 2019 assignor set (ALIPHCOM, LLC and BODYMEDIA, INC.) is a non-operating remnant; Jawbone's business wound down after 2017; and the sequencing at 049805/0582 (title transferred 07-19) versus the BlackRock release (08-08) fits a distressed negotiated sale. But I found no Chapter 7 or Chapter 11 docket, no §363 sale order, and no claims-transfer docket for this portfolio. Inferred distress is not a recorded bankruptcy sale; flagged accordingly.

7. Privateering — NOT PRESENT.
The 2013 event was a straight operating-company acquisition: AliphCom/Jawbone buying BodyMedia for a reported >$100M, with BodyMedia's armband products continuing to ship. Jawbone is not an NPE asserting on a supplier's behalf. The nearest thing to a privateering precursor is BodyMedia's own 2006 public statement of licensing intent ("the best ways to… foster growth in the… industry through the use of our intellectual property rights") — but that is a licensing posture by an operating company, not a transfer to an NPE.

8. Defensive aggregator — NOT PRESENT.
No RPX, AST, LOT Network, Unified Patents or Open Invention Network entity appears anywhere in the chain. The chain terminates at JB IP Acquisition LLC.

Verdict

NPE — moderate confidence.

The load-bearing record is the 2019-07-19 assignment at reel 049805/0582, which moved title out of two non-operating ALIPHCOM/BODYMEDIA entities into JB IP Acquisition LLC, an "IP"-suffixed vehicle — followed within four days by a UCC financing statement and security interest to J Fitness LLC at reels 049825/0718 and 049825/0907, and then by near-immediate corelease of the BlackRock lien (2019-08-08). That is one strong NPE signal (transfer to a non-practicing IP-holding acquirer out of a wound-down operating group). It is not two, because the correspondent-of-record field — the decisive test for connected shell entities — and the assignee's address/member data were not retrievable, leaving signals 2, 3 and 6 unclear rather than established. Note also that this patent is now expired (term ended 2022-10-21, consistent arithmetically with the 2002-08-22 filing date plus a ~60-day period adjustment — not a maintenance-fee lapse), so any NPE characterization is historical rather than describing a live assertion campaign.

Two flags for the earlier sections

1. Correction/addition, not contradiction. The earlier "Patent summary" section listed a potential reexamination certificate as its largest uncertainty but did not surface the 2012–2013 reexamination campaign. A D. Del. order of June 6, 2013 records that Basis Science filed seven inter partes reexamination requests against the asserted patents in 2012, that six had been granted by December 2012, and that the case was stayed pending reexamination. The order itemizes grants for the '690, '038, '090, '437 and '707 patents — it does not itemize a '508 grant. So the existence of a campaign is now confirmed, but whether a reexamination certificate issued for the '508 specifically, and what it did to claims 1–222, remains unverified. The earlier uncertainty stands, now better bounded.
2. Standing uncertainty unchanged. I still found no 2026 CAFC docket, opinion or argument-calendar entry naming US 7,020,508. Absence of hits is not proof of absence.

I'll pull the front-page references (US patents, foreign documents, and other publications) cited on the face of US 7,020,508, then verify the key ones.

The front-page citation list didn't come through cleanly. Let me fetch the issued PDF and Google Patents citation table directly.

Let me try patent databases that expose the front-page reference list in text form.

Prior Art Analysis — US 7,020,508 B2

0. Verification statement up front (read this before the tables)

I could not retrieve the authoritative front-page "(56) References Cited" list for US 7,020,508. This is not a retrieval inconvenience I can paper over — it changes the shape of the answer:

• The authoritative full text supplied in the task (the Google Patents rendering) is a stripped version that contains the abstract, the "Definitions" narrative, the figure list, the classification tree — but no citation tables at all. There is no "Patent Citations," no "References Cited," and no "(56)" block in the material I was given.
• My independent searches returned, overwhelmingly, forward citations (later patents citing the '508) rather than the '508's own backward citations. Those are not prior art and I will not present them as such.
• I found no secondary source that reproduces the '508's examiner/applicant citation list in text.

Therefore: I am not going to produce a list of 20+ references with dates and claim mappings. Anything of that kind would be fabricated, and given that some of the "citations" that circulate for this family are actually citations from sibling applications (e.g., the PCT search reports for WO2006038948A1 / WO2005055914A1), a fabricated list would be actively misleading. What follows is (a) the framework, (b) the references I could actually corroborate, (c) a structured, labeled candidate analysis by claim family, and (d) the one § 102 question that actually decides this patent's validity.

Literal identifier discipline: I searched for 7020508 only. I did not merge in 7,069,508, 7,029,508, 7,020,588 or any other near-miss. See §6.

1. What "prior art for 7020508" can and cannot be, mechanically

Three structural facts control everything downstream:

Claim-family map (from the earlier-generated section, reused not repeated):

2. References I could actually corroborate (partial, and I say how far each is verified)

These surfaced in my searches in connection with this patent family. Verification level is stated for each. None of these is confirmed to appear on the face of the '508.

Hard caution on the PCT search-report lists: the WO2016044933A1 and WO2006038948A1 search reports I retrieved enumerate references and "relevant passages" for the applications those reports cover (PCT/CA2015/050938; PCT/US2005/023666) — not for the '508. Candidates appearing in those lists (e.g., US 5,398,700 A (Mills et al.), 1995-03-21; US 6,615,836 B1 (Riesbach et al.), 2003-09-09; US 5,845,641 A (Pinney et al.), 1998-12-08; US 4,089,331 A (Hartigan et al.), 1978-05-16) are plausible art for Families A and C, but I have zero evidence any of them was cited on the '508. They are search leads, not findings.

3. Candidate prior art by claim family — labeled, not asserted

Everything in this section is a hypothesis to be verified against the actual (56) list, except where marked corroborated. I have deliberately not manufactured dates for references I could not see.

Family C — heat flux with a known-resistivity base member (claims 42, 65; Fig. 26) — highest diligence priority

The claim architecture — two temperature sensors on opposite faces of a substrate of preselected, known resistivity, skin-side one coupled through a "thermal energy communicator," ambient-side one exposed, heat flux = K(T₂−T₁) — is the narrowest and most vulnerable set of claims in the patent, because the physics is textbook and the sensor stack (thermopile/thermistor sandwich on a known-thermal-resistance substrate) has decades of prior art in calorimetry, wearables and industrial heat-flux measurement. Expect the examiner to have cited medical calorimetry / indirect-calorimetry art and heat-flux sensor art, not wearable-computing art, against claims 42 and 65.

• Anticipation target: claims 42 and 65, and dependents reciting thermistor/thermocouple/thermopile choice and the specific thermal-interface materials. A single reference disclosing a two-thermistor sandwich on a known-K substrate with a skin conduit would take these outright under § 102(a)/(b) if published before 2001-08-22 (i.e., more than a year before filing — much heat-flux art is far older, so § 102(b) applies).
• Corroborated starting point: none. This is a gap I must flag as a gap.

Family D — adhesive patch with derived/analytical data (claims 68, 128, 185–202) — widest exposure

This is the largest independent-claim family (≈15 independents), which means it is also the family with the most different ways to be anticipated. Split it:

• The hardware half (adhesive exterior surface + ≥2 physiological/contextual sensors + processor + memory) — anticipate via adhesive physiological sensor patch / disposable biosensor art pre-2001-08-22.
• The "derived data" half (a parameter that cannot be directly sensed, e.g. calories, sleep onset, stress) — anticipate via indirect calorimetry / energy-expenditure estimation art and sleep-staging art, both mature well before 2002.
• The "analytical status data" half (feedback on adherence to a predetermined multi-category routine) — anticipate via patient-compliance / outcomes-management / telemedicine reporting art.
• Anticipation targets: claims 68, 128, 185, 186, 187, 199 on the hardware+derived-data combination; 84–85, 194–195 (the routine-adherence claims) on compliance-monitoring art.

Note the practical reality: claims this broad are more likely to die on § 103 than on § 102, so a pure anticipation-based attack understates the exposure. The earlier-generated NPE/litigation sections are relevant here — this family is why the patent was commercially interesting.

Family G — GSR electrodes, wear-detection, microneedles (101, 104, 108, 113, 143, 152, 161, 184)

• GSR with two contacts — galvanic skin response measurement is 19th-century art; the textured/raised-bump and oblong-curved electrode geometry claims (101–104, 146–148, 183) are the novelty hook and are the ones to attack with biomedical electrode art.
• Proximity sensor to detect wear / auto power on-off (claims 108, 113) — anticipate via wristwatch / wearable-device power-management art. These are weak, narrow claims.
• Microneedles to penetrate the stratum corneum (143, 152, 161, 184) — microneedle transdermal art was well developed by 2001–2002 (drug-delivery and interstitial-fluid-sampling literature). Claims 143/152/161/184 reciting microneedles on a skin-contacting sensing component are the clearest § 102(b) targets in the whole patent if any pre-2001-08-22 microneedle-sensor publication is cited.

Family H — acoustic non-ECG heart sensing with motion/ambient-noise subtraction (203, 204, 210, 221; methods 126, 205, 207, 212)

Structurally, these claims read on "acoustic heart sensor signal minus accelerometer-derived motion reference minus ambient-noise reference." The obvious art class is electronic auscultation / electronic stethoscope with noise cancellation plus adaptive noise cancellation generally (the Widrow adaptive-noise-canceller literature is 1970s–1980s). If the examiner cited any electronic-stethoscope patent with a motion or ambient reference channel, claims 126, 203, 205, 207, 212, 221 are exposed under § 102. I could not corroborate any specific reference here — flagged as unverified.

Family A / B — removable housing and switch-based reconfiguration (1, 10, 12–21, 213, 164, 171, 178, 217, 64)

• Family A is largely mechanical mounting art: tongue-and-groove, magnets, elastic band in a groove, pressure-only retention. Expect § 102(b) art from holster / removable-module / watch-band patents. Claims 2–6, 22–26 are narrow enough that a single well-chosen mounting reference can anticipate them.
• Family B (auto-reconfiguration based on which strap/flexible section is attached, via magnetic/mechanical/optical/electrical switches) is a § 102(e)/§ 103 target: the concept of an accessory identity resistor or magnet tripping a switch to select device parameters is standard art (think battery-type ID resistors, accessory-detection in portable electronics). Claims 12–21 and 64.

Family E and F — left-chest heart sensing; concave/convex inner surface

• Family E (36, 41, 180, 208, 209) — garment-mounted heart sensors. The limitation doing the work is positional ("left chest"). That is a § 102(b) target only if a reference expressly recites left-chest placement; otherwise it is a § 103 configuration claim.
• Family F (89, 90–100, 168–170, 174–176) — this is likely the least-prior-art-burdened family; concave-along-longitudinal-axis / convex-along-transverse-axis skin-contact geometry is a genuinely specific ergonomic recitation. Expect thin art. Note, however, that a shape claim can be anticipated by a product (public use / on-sale) rather than a patent, which raises the BodyMedia-armband question below.

4. The one § 102 question that actually decides this patent: BodyMedia's own 1999–2000 filings

This is the highest-value point in this analysis and it is not something a generic citation scrape surfaces.

The '508 (filed 2002-08-22) sits in the same corporate portfolio as a group of BodyMedia applications claiming priority to 1999-10-18 and 2000-06-16 — the US 6,527,711 / US 6,605,038 / US 7,153,262 / US 7,285,090 / US 7,689,437 / US 7,261,690 / US 8,073,707 group, some of which name Stivoric and Teller as inventors. Two mutually exclusive outcomes:

(a) If the '508 does not claim § 120 benefit of those 1999/2000 applications (Google Patents lists the '508's priority date as 2002-08-22 — but that field is expressly "an assumption… not a legal conclusion"), then those earlier-filed BodyMedia applications are § 102(e) prior art to the '508. That is potentially catastrophic for the broad independent claims, because the same specification content would be "effectively filed" years before the '508. Pre-AIA § 102(e) requires the reference be "by another"; where the inventive entities are partially overlapping but not identical (In re Land, In re DeBaun line), the reference still counts as "by another," and § 103(c) common ownership (available for applications filed on/after 2004-12-10) would block obviousness combinations but not anticipation.

(b) If the '508 does claim benefit of a 1999/2000 parent, then those siblings are the same family and are excluded as prior art — and the '508's effective filing date moves back, which shrinks its own art window but removes the self-collision.

I could not determine which is true. The '508's specification as supplied contains no cross-reference to a prior application, which is mild evidence for (a), but absence of a cross-reference in a stripped OCR rendering proves nothing.

Corollary — the § 102(b) product risk. If (b) is true and the '508's effective date is 1999, the § 102(b) critical date moves back accordingly and BodyMedia's own SenseWear / BodyMedia armband (which the earlier analysis found "not a paper patent" — BodyMedia's own 2006 press release describes the '508 as covering the commercial armband architecture) becomes a public-use / on-sale candidate. I could not verify any BodyMedia product launch or offer-for-sale date, so I am not asserting an on-sale bar — I am flagging it as the second thing to determine, because a product that practises claims 1, 68, 89 or 213 and was public before the critical date is § 102(b) art regardless of who made it.

5. Do not analyze anticipation against "the patent" — the claim set has a live integrity question

The earlier-generated sections flag an unresolved Reexamination Certificate on the '508 and a 2012–2013 inter partes reexamination campaign by Basis Science. This matters directly to a § 102 mapping:

• If a certificate canceled or amended any of the 222 claims, then any claim-numbered anticipation table (including the candidates in §3 above) is keyed to numbers that may no longer exist.
• The D. Del. 6/6/2013 order (per the earlier section) itemized reexam grants for the '690, '038, '090, '437 and '707 patents but did not itemize a '508 grant — so the certificate question remains open, not answered.

Do not quote claim numbers as operative until the certificate is pulled.

6. Same-number / near-number false positives to avoid when searching "7020508"

Per the operating rule I report these literally rather than silently correcting them:

That last row is the single biggest trap in this task: searching "7020508" is dominated by forward citations, and a careless sweep will present a dozen post-2006 wearables as though they were prior art to a 2002 filing.

7. Explicit uncertainty list

1. The (56) reference list itself was not retrieved. This is the primary limitation of this analysis and it is not resolvable from the sources I reached.
2. Whether the '508 claims § 120 benefit of the BodyMedia 1999/2000 applications — undetermined; controls §4 entirely.
3. Whether a Reexamination Certificate issued and amended claims 1–222 — undetermined; controls the validity of any claim-numbering.
4. No specific reference could be corroborated as cited on the '508's face. Every candidate in §3 is labeled as a hypothesis except where corroboration is noted in §2.
5. No on-sale/public-use date for a BodyMedia product was verified; the § 102(b) product theory is flagged, not asserted.
6. Examiner identity and examiner's own applied references were not retrievable (one search hit a "Patent Primary Examiner" field but returned no value).
7. Date inconsistency in the task framing: the task states "Current Date: April 26, 2026," while the governing system date is 2026-09-29. Nothing in the prior-art analysis turns on the gap, but the record should note that the previously generated sections are stamped April 2026.

8. What to do to actually answer the question

To produce the reference-by-reference table the task asks for, get the citation list from a source that carries it — ranked by reliability:

1. The issued PDF front page (patentimages.storage.googleapis.com/…/US7020508.pdf, byte-identical to the printed (56) block) — the examiner-signed list, US patents + foreign documents + other publications, with examiner and art unit.
2. USPTO PatentCenter / Patent Full-Text (patft) for 7,020,508 — "References Cited" and "Referenced By," plus the examiner's search notes and any PTO-892.
3. The reexamination file (if one exists) — which would also resolve item 3 above and may substitute the examiner's reexam-art citations, often more on-point than the original.
4. The prosecution history via Global Dossier — for the applicant's IDS, which frequently contains non-patent literature (the "Health Manager" and BodyMedia-press references that show up as "Other Publications" in this family's later patents) that never appears in a patent-database citation table.

Once that list is in hand, the mapping in §3 is ready to be applied claim-by-claim, and §4 is the first question to answer — because if the '508 does not claim the 1999/2000 priority, the most dangerous § 102(e) art to this patent is not a third party's at all; it is BodyMedia's own earlier application.

I'll first try to locate the prior-art citations of record for the '508, since the authoritative text I was given contains only the "Prior art keywords" field and the 2002-08-22 prior-art date — not a References Cited table.

Strong lead found: the EP search report for the '508 family cites US 2002/019586 A1 (Teller et al.) as an X-reference. Let me pin down that reference and the other key prior art.

Obviousness Analysis — US 7,020,508 B2 under 35 U.S.C. § 103

Note on scope and one premise that cannot be executed as stated. The task directs me to "use the results from the Prior Art section of this page." No prior-art section exists in the material supplied. The only prior-art fields in the authoritative text are Google Patents' tag block — Prior art keywords: housing, sensors, sensor, physiological, parameters — and Prior art date: 2002-08-22. There is no References Cited table, no examiner-cited list, and no applicant IDS in the text I was given, and no earlier generated section covered prior art. Rather than invent one, I have grounded the analysis below in retrieved family prosecution/reexamination records (which are prior-art records of this family) plus explicitly flagged general knowledge. I also flag a date inconsistency: the system date is 2026-09-29 while this task states 2026-04-26; the earlier sections used both. Nothing turns on it, but it is a record inconsistency.

1. Governing framework

• Statute: Pre-AIA § 103(a) governs (application filed 2002-08-22, before the 2013-03-16 AIA change). Graham v. John Deere Co., 383 U.S. 1 (1966); KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007).
• Critical-date arithmetic that drives everything: with a 2002-08-22 filing, the § 102(b) line is 2001-08-22. Art published before that date is § 102(b) prior art and cannot be disqualified under § 103(c). This is the single most useful fact for any challenger and I return to it in § 3.
• Claim construction: for this expired patent (2022-10-21), the Board applies the Phillips framework; district courts likewise. Most independents are drafted in functional/"adapted to" form ("processor adapted to generate derived data…"), which broadens the prior-art exposure rather than narrowing it.
• PHOSITA (proposed): a person holding a B.S. in electrical, mechanical, or biomedical engineering (or equivalent) with ~2–4 years designing body-worn, battery-powered physiological monitors — multi-sensor ambulatory devices combining ECG/heart-rate, accelerometry, thermometry, and skin-conductance channels — familiar with the clinical energy-expenditure and sleep-staging literature and with low-power consumer-electronics integration. The inventors were themselves such a multi-disciplinary team; the specification reads as a synthesis of known sensors, which cuts against a narrow PHOSITA.

2. The prior-art corpus actually available

3. The threshold issue that can defeat the strongest combinations: § 103(c)

Two of the most on-point references run straight into pre-AIA § 103(c)(1):

1. US 2002/019586 A1 (Teller et al.) is a BodyMedia application. The '508 was filed by the same assignee, and its four inventors (Stivoric, Boehmke, Teller, Kasabach) were BodyMedia personnel. Subject matter commonly owned "at the time the invention was made," qualifying as prior art only under § 102(e), may not be used for obviousness.
2. US 6,595,929 (the dedicated "improved measurement of heat flow" patent) granted after the '508's filing date, so it can only be § 102(e)/(g) art — and is likewise common-owned.

Two escape routes, both requiring work:

• 102(a) rather than 102(e): US 2002/019586 published 2002-02-14. If the '508 invention was not reduced to practice before that date, the '586 is § 102(a) art (not "only" 102(e)) and § 103(c) does not reach it. The patentee would then have to swear behind under Rule 131 with corroborated evidence. The challenger should force that issue — it is the pivot on which most of the Family D case turns.
• Use a different primary: replace the '586 with § 102(b) art (Amano, Ward, Lester, Tammi, Myllymaki, Brown — all pre-2001-08-22) so § 103(c) is irrelevant.

This also explains the transatlantic asymmetry and is worth flagging as an analytical insight, not a contradiction: the EPO examiner validly used the '586 as X art because for the EP/PCT filing (2003-08-21) the '586's Feb-2002 publication was more than 18 months old and therefore ordinary Art. 54(2) state of the art usable for inventive step. For a US filing of 2002-08-22 that same publication was only six months old and thus reaches only § 102(a)/(e) — where § 103(c) bites. Do not assume the EP X-citation translates into a US § 103 problem.

4. Family-by-family obviousness case

Claim-family lettering follows the mapping in the Patent summary section; I do not re-derive it.

Family C — measured heat flux over a known-resistivity base member (claim 42; see also 65) — strongest § 103 case

Combination C-1: Amano (US 6,030,342) + Pottgen.

• What each teaches: Amano — a wearable calorie-expenditure device computing expenditure from pulse rate, body temperature and a body-motion detector, using selectable "active"/"resting" regression formulae and outputting an "achievement rate." Pottgen — a heat-flow sensor element for measuring conductive/convective/radiant/evaporative heat flow, expressly including "thermopile, thermistor, and thermocouple-based heat flow sensor elements," and expressly computing calorie expenditure from measured heat flux.
• Motivation: both references target the same problem — quantification of energy expenditure from a body-worn device. Amano's own technique is indirect (it uses body temperature only as a threshold/regression selector, as the patentee itself argued, unsuccessfully). A PHOSITA seeking a more direct and more accurate measure of metabolic heat loss would add Pottgen's heat-flux channel as an additional physiological parameter, because heat flux measures the quantity Amano is trying to estimate. The Board adopted exactly this reasoning, and rejected the patentee's "different problem / teaching away" defense: "It is prima facie obvious to use a known technique to improve similar devices" (MPEP § 2143; In re Keller, 642 F.2d 413, 425 (CCPA 1981)).
• Remaining limitations (claim 42): "base member having a preselected, known resistivity"; the heat flux computed from the two temperature readings and that known value; a "thermal energy communicator" between body and the first temperature device; and the vertical alignment of the stack normal to the board.
  • Second combination C-2 (for the "known resistivity"/"thermal energy communicator" elements): Amano + Pottgen + the thermal-engineering knowledge of thermal interface materials — gap fillers, thermal greases, phase-change materials, thermally conductive tapes, and metal (e.g., stainless-steel) interface plates — used to minimize interfacial thermal contact resistance. This is textbook heat-transfer practice, and the motivation is intrinsic: uncorrected contact resistance corrupts the ΔT measurement that the flux calculation depends on. The "preselected, known resistivity base member" is simply the substrate of a resistance-type heat-flux sensor — i.e., the implementation of q = ΔT/R where R is a known thermal resistance. That is the definition of the device, not an invention.
  • The "vertically aligned normal to the board" limitation is a manufacturing/stack-up choice (PCB-mounted sensor facing the skin), squarely within KSR's "predictable variation."
• Strength: high. Both primary references are § 102(b), so § 103(c) is unavailable. The Board has already sustained an analytically identical combination against a sibling BodyMedia patent.

Family D — adhesive-backed housing with derived/analytical status data (claims 68, 128, 185–202) — high vulnerability, contingent on § 103(c)

Combination D-1: US 2002/019586 A1 (Teller) + Ward US 4,509,531 + a conventional display/memory.

• The '586 is, per the EP report, of record as disclosing (with paragraph cites) the physiological-sensor data architecture of the family: sensor device generating physiological and contextual data, microprocessor-derived information, and the identified paragraphs corresponding to the "derived data / analytical status data / routine adherence" architecture in Tables 1–2 — i.e., the substantive core of Family D. Ward adds a body-attached personal health monitor.
• Motivation: the adhesive patch is the direct answer to the two design pressures the specification itself names — wearability/unobtrusiveness and continuous ambulatory data capture. Substituting a body-conformable adhesive patch for an armband strap is KSR category (B) simple substitution of one known element for another, yielding the predictable result of a lower-profile, single-use or fixed-site monitor. A PHOSITA integrating the '586's electronics into Ward-style body attachment would arrive at the claimed apparatus.
• Caveat, stated plainly: if the '586 is disqualified under § 103(c) (see § 3), this combination collapses and must be rebuilt on non-commonly-owned primaries (Ward/Lester/Tammi/Brown + conventional processor/display/memory + § 102(b) art showing derived-parameter reporting, e.g., the Amano "achievement rate"). Brown US 6,248,065 (listed on the '437 front page, class 600/300) is a candidate for the remote-reporting/analytical-data element, but I did not read it and cannot yet assert what it discloses.
• The "degree to which the wearer followed a predetermined routine" sub-features (claims 84–85, 194–195) are well supported by Amano's express "achievement rate G = (summed value / target value) × 100" teaching, which the Board held to be quantitative status information against a physiological goal. That is a strikingly close analogue to a routine-adherence score.

Family A — housing removably attached to a flexible section / strap (claims 1, 10, 213, 164, 171, 178, 217) — moderate-to-high vulnerability

Combination A-1: US 2002/019586 A1 (or Teller '038-family disclosure) + a detachable-module teaching (Tammi US 5,622,180; Myllymaki US 5,410,471 / 5,670,944; or a Holter electrode belt).

• Motivation — and here the patent itself supplies the best evidence: the '508's own drawing schedule includes Fig. 19, "the sensor device … inserted into a battery recharger unit." A device that must be periodically docked for charging inherently creates the design incentive to separate the electronics from the body-worn carrier. Add the ordinary motivations of hygiene (washable strap), fit/replacement (worn-out straps), cross-user reuse, and body-site flexibility, and the claimed tongue-and-groove, magnet, elastic-band-in-groove and adhesive mounting variants (claims 2–6, 22–26) reduce to the selection of a known fastening expedient from a finite, fully enumerated set — KSR category (E), "a finite number of identified, predictable solutions."
• Strength: high on motivation, moderate on reference specificity. The detachable electronics pod on a chest strap was routine in heart-rate-monitor practice by the late 1990s (Tammi/Myllymaki are listed in the sibling's cited art), but I have not verified those disclosures at the element level.

Family B — automatic reconfiguration based on which flexible section is attached (claims 10, 12–21, 64) — legally vulnerable, evidence gap

Combination B-1: a multi-sensor body-worn monitor (e.g., the '586 armband) + accessory-identification art.

• Motivation: the claimed function is to select operating parameters/profile based on which strap is attached. The design incentives are error-avoidance (right calibration for the right limb/site/user), single-pod-across-product-family economics, and the obvious need to prevent a user from applying a calf band while the device assumes an arm. The mechanisms enumerated in the claims — magnetic (reed switch), mechanical (protruding pin), optical (blocker/reflector/filter), electrical (conductor) — are four of the standard, and collectively exhaustive, families of binary/analog accessory identification used in battery packs, game controllers, medical probes and power tools of the era.
• KSR posture: "combining familiar elements according to known methods [to yield] nothing more than predictable results" — the strongest possible articulation.
• Evidence gap — be candid: I did not retrieve a specific secondary reference teaching accessory-ID → parameter reconfiguration. This is the combination I would escalate first with a targeted search (USPC/CPC A61B 5/00 + G01R/H01H + "identify accessory/coded resistor/reed switch").

Family E — left-chest / garment-mounted heart sensing (claims 36, 41, 180, 208; cf. 163, 209) — high vulnerability

• Motivation: purely anatomical. The heart is in the left hemithorax; the precordium has been the ECG electrode site since Waller and Einthoven. Combining any wearable heart-parameter sensor (Lester '125/'831 ambulatory ECG; Tammi/Myllymaki HR monitors; a garment-integrated electrode shirt) with the stated placement is KSR category (D) — applying a known technique (standard precordial/chest electrode placement) to a known device (a body-worn monitor) — with a predictable, indeed foreordained, result. The "sensor for mechanical action of the heart / heart sounds" alternative is equally answered by conventional auscultation sites (see Family H).
• A PHOSITA would not need hindsight: the placement is dictated by the anatomy the device is measuring.

Family F — housing inner surface concave in one direction, convex in the other (claim 89; cf. 90–100, 168–170, 174–176) — moderate vulnerability, search burden

• Motivation: the stated problem — retaining skin contact as the underlying muscle flexes and relaxes — is a known, inherent property of the upper arm (biceps/triceps cross-section changes with contraction). A compound-curved shell is the routine engineering answer, and double-curvature to conform to a limb is ubiquitous in watch cases, bracelet links, oximeter probes and orthoses.
• The patentee's best argument: the specific polarity combination (concave about the longitudinal axis and convex about the transverse axis) with radiused lateral ends and tapered sides is not obviously a "design choice" if no reference shows that compound geometry. Counter: KSR category (F) — known work in a field (body-contacting shells) prompting variation based on design incentives — plus the claim's own functional justification. Flag: I did not verify a body-contacting-shell reference; this combination needs one, and its absence is the main reason I rate this moderate rather than high.

Family G — skin-contact structures and wear detection (claims 101, 108, 113, 118, 143, 146, 152, 161, 183, 184) — high vulnerability

Three sub-combinations:

• G-1 (textured/raised-bump GSR electrodes; claims 101–104, 146–148, 183): body-worn monitor + conventional dry-electrode design. Motivation: reduce skin-contact impedance, defeat hair and the stratum corneum, and stabilize contact under motion — all standard electrode engineering. The '586/armband disclosure already contemplates GSR electrodes of conductive carbonized rubber, gold or stainless steel (as quoted in IPR2016-00543 Ex. 1013), so surface texturing is a predictable mechanical variant.
• G-2 (proximity sensor to detect wear / auto power-on; claims 108, 113): wearable monitor + known on-body detection. Motivation: battery life and data validity — do not log when the device is on a nightstand. On-body/wear detection by mechanical switch, capacitive proximity, or a strap-closed contact was a commonplace pairing in watches and monitors.
• G-3 (microneedles through the stratum corneum; claims 143, 152, 161, 184): body-worn sensor + the transdermal microneedle art of the late 1990s. Motivation: the limitation itself states the purpose — penetrate the stratum corneum for better electrical contact and/or interstitial-fluid access. KSR category (C), "use of a known technique to improve similar devices," is directly on point; the microneedle field was intensely active pre-2001 for both drug delivery and transdermal sensing. Flag: I did not verify a specific microneedle reference in this session, and I decline to supply a number from memory. This must be searched before it is relied on.

Family H — acoustic, non-ECG heart sensing with motion and ambient-noise cancellation (claims 203, 204, 210, 211, 221, 222; methods 126, 205, 207, 212) — conceptually strong, evidence gap

Combination H-1: a conventional electronic stethoscope (contact sound transducer) + an accelerometer-derived motion reference signal + ambient-noise reference + adaptive subtraction.

• Motivation: the claimed problem — heart sounds contaminated by footfall/body-motion noise and ambient noise in an ambulatory setting — is the defining problem of ambulatory auscultation, and the reference-channel/adaptive-subtraction solution (measure the noise separately, then subtract) is the canonical engineering response and standard textbook signal processing. A PHOSITA combining (i) electronic auscultation, (ii) accelerometer-based motion-artifact rejection as already used in ambulatory monitors, and (iii) reference-microphone ambient-noise cancellation would reach the claimed method with a predictable result. This is KSR categories (C) and (E) in their purest form, and note that the claim language itself ("using the second signal to subtract") is functional and broad.
• Evidence gap — the largest in this analysis: I could not retrieve a specific noise-cancelling electronic stethoscope or footfall-artifact reference. I will not fabricate one. My assessment of vulnerability is doctrinal and problem-driven; a challenged claim here would stand or fall on the actual references found. Given the breadth of the independent claims and the low specificity of the "one or more filtering sensors" language, I would also expect a § 112 attack to be as productive as § 103.

Cross-cutting dependents — sensor "menu," display, wireless, manual entry (e.g., claims 7, 8, 27–29, 35, 73, 78–79, 83, 88, 132, 155, 161, 190, 197, 198) — very high vulnerability

The specification is self-defeating here and this should be quoted in any petition:

"Methods for generating data indicative of various physiological parameters and sensors to be used therefor are well known."
"Such sensors are well known, as are methods for generating contextual parametric data such as air quality, sound level/quality, ambient temperature and global positioning."
"It is to be understood that other types of data relating to other parameters can be generated… without departing from the scope of the present invention."

These are applicant admissions that each menu element (GSR, skin temperature, ambient temperature, accelerometer, ambient light, ambient sound, EMG, ECG, skin impedance, heat flux, heart-related) is conventional, and the specification expressly says the derived-information calculations use "known methods." A § 103 rejection of these dependents needs only: a body-worn multi-sensor processor (Amano; the '586; Tammi; Lester) + the conventional sensor itself + the ordinary motivation to add channels that improve the accuracy of the very calculation the device is performing — which the Board accepted in the '437 reexam ("a more accurate determination of whether a user is at rest or active"). The display / LED / LCD / electrochemical display, wireless transceiver, shared computing, and button/keypad/touch-pad dependents are the classic case of applying known consumer-electronics features to a known device, where the only asserted advantage (portability, user feedback, data offload) is inherent in the feature's known purpose.

5. Why a PHOSITA would combine — the motivation synthesis

Mapping the case onto the KSR rationales:

Three specific motivation arguments I would lead with, because each is grounded in the record rather than in hindsight:

1. Same problem, same metric. Amano and Pottgen both compute caloric expenditure. Amano does it indirectly; Pottgen measures the underlying heat directly. Adding a direct measurement of the quantity you are estimating is the paradigm of an obvious improvement — and the Board so held for the sibling patent.
2. The specification's own design pressures. The '508 describes a rechargeable device with a docking/recharger (Fig. 19), multiple interchangeable flexible sections, and an explicit concern with maintaining skin contact as the body moves. Those are the admitted design problems; the claimed solutions are the standard answers. Using the applicant's own specification to supply the motivation is orthodox and non-hindsight.
3. Convergence of the field. Between roughly 1995 and 2002 the art was visibly converging on continuous, ambulatory, multi-sensor body monitoring with derived-parameter reporting (Amano; Pottgen; Tammi; Myllymaki; Ward; Lester; Brown; Mault). The '508's contribution is largely architectural bundling of that convergence into an omnibus claim set — which raises § 103 exposure across dozens of independents rather than lowering it.

6. Secondary considerations

• Commercial success — plausible but nexus-weak. The SenseWear armband shipped and BodyMedia was acquired by AliphCom/Jawbone in 2013 for a reported >$100M. To carry weight, the patentee must show nexus — that the success was driven by the claimed features rather than by the software/service ecosystem, brand, distribution, the clinical-research API, or unclaimed features. Expect an uphill fight given how much of the commercial value resided outside the claims.
• Licensing / industry recognition. BodyMedia's own 2006 statement of intent to grow the industry "through the use of our intellectual property rights" cuts both ways: it shows the portfolio was regarded as foundational, but it also signals a monetization posture rather than evidence that competitors had failed to solve the problem.
• Long-felt need. The patentee will argue that continuous, unobtrusive, multi-sensor monitoring was long sought. The counter is strong: the references show the need was being met, incrementally, throughout the 1990s.
• Teaching away — weak here. The patentee argued in the '437 reexam that Amano (which uses temperature merely as a threshold/regression selector) taught away from heat flux; the Board rejected that argument ("Nothing in Amano … suggests a heat flow sensor would provide a more accurate determination" was the patentee's framing; the Board found no teaching away and sustained the rejection). A '508 challenger can borrow that reasoning.
• Copying. Difficult to establish; the Fitbit/Jawbone disputes were largely trade-secret and different-patent in character.
• Expiry. With the term ended 2022-10-21, secondary considerations now bear only on historic damages (and § 286's six-year lookback bites hard). They will not support injunctive or forward-looking relief.

7. The patentee's strongest counterarguments (and my honest assessment)

1. § 103(c) common ownership — the best defense, and it is a legal defense, not a technical one. It disarms the '586 (the EP X-reference) and US 6,595,929 (the heat-flow sibling). For a US § 103 attack this is the threshold battle. The challenger must either (a) put the '586 in under § 102(a) and force a Rule 131 swear-behind, or (b) rebuild on § 102(b) art.
2. Non-analogous art for the acoustic/stethoscope and microneedle references. Post-KSR this is a weak defense — the test is whether the art is from the same field of endeavor or reasonably pertinent to the problem — and the problem (ambulatory heart-sound capture) is expressly stated.
3. "Bodily incorporation" versus "combined teachings." The patentee will argue no reference suggests combining. In re Keller forecloses the framing ("the test is not whether the features of a secondary reference may be bodily incorporated…").
4. Claim breadth is a two-edged sword. The 57 independents are drafted functionally and broadly; that enlarges the prior-art exposure. But breadth also means no single reference anticipates everything, so a challenger must run dozens of parallel mini-cases — which is expensive and, on an expired patent with a short damages tail, may not be worth funding.
5. Claim-text uncertainty (most important practical caveat). The earlier sections flag an unresolved reexamination certificate on this patent (uspto.report's grant record: "Please see images for: (Certificate of Correction) (Reexamination Certificate)"). The 2012 Basis Science campaign (seven inter partes reexamination requests; six granted by December 2012) is confirmed by the D. Del. 6/6/2013 stay order, but that order itemizes '690, '038, '090, '437 and '707 — not the '508. If a certificate amended or cancelled any of claims 1–222, every family mapping above must be re-run against the operative text. Do not quote claim language as operative until the certificate is retrieved.

8. Bottom line — vulnerability ranking

The single sentence answer: the cleanest § 103 attack on the '508 is Amano + Pottgen against the heat-flux claims (Family C) and the sensor-menu dependents, because both references are § 102(b) art immune from § 103(c), the Board has already sustained an analytically identical combination against the sibling '437 patent, and the specification itself concedes that the sensor-level subject matter is "well known"; the strongest resistance the patentee has is the § 103(c) common-ownership shield over the Teller '586 and the US 6,595,929 heat-flow references — which means a challenger who leads with the EPO's X-reference may find the ground removed beneath them.

9. Uncertainties, and contradictions with the earlier sections

Contradictions / flags:

1. Task premise cannot be executed. There is no Prior Art section in the supplied page content — only the Google Patents "Prior art keywords" and "prior art date" fields. The earlier generated sections likewise contain no prior-art section. I have substituted retrieved family prosecution/reexamination records and have said so at every point where general knowledge rather than a retrieved document is doing the work.
2. Date inconsistency. System date 2026-09-29 vs. this task's "2026-04-26"; the earlier sections used both. Immaterial to the analysis, but it is a record defect.
3. Priority-date variance (previously flagged, now re-confirmed). Google Patents gives 2002-08-22; the Unified Patents portal entry for US-7020508-B2 gives 2002-08-21. Same one-day variance noted in the Patent summary. It does not change the § 102(b) line in any practical way.
4. No contradiction with the earlier sections in substance. This analysis is consistent with, and depends on, two of their open items: the unresolved reexamination certificate (which governs operative claim text) and the verified fact that the adjacent BodyMedia defeats were on the '707 and '437, not the '508. I have used those results only as evidence of the art's predictability, not as holdings on the '508's claims.

Unverified items I explicitly decline to over-claim:

• The patent number of "Pottgen" — the '437 front page lists "5,515,865 A 4/1996 Pottsen et al." which may or may not be the same reference; unconfirmed.
• The disclosures of Tammi '180, Myllymaki '471/'944, Ward '531, Lester '125/'831, Brown '065 — verified only as listings on the sibling '437 front page.
• Any specific electronic-stethoscope/noise-cancellation, microneedle, or accessory-identification reference. I have named these as search targets rather than supplying numbers I could not verify.
• Whether US 2002/019586 A1 is § 102(a) (and thus outside § 103(c)) or § 102(e)-only — this turns on the '508's actual invention date and is the pivotal factual question for Families A, B and D.

Recommended next evidentiary steps: (i) retrieve the '508's full IDS/References Cited and any reexamination certificate; (ii) retrieve US 2002/019586 A1 and confirm the invention date to settle § 103(c); (iii) confirm Pottgen's number and disclosure; (iv) search pre-August-2001 art for accessory-ID and body-contacting-shell references (Families B and F); (v) search pre-August-2001 ambulatory auscultation/noise-cancellation and transdermal microneedle art (Families H and G-3).